These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25624622)

  • 1. Toll gates: An emerging therapeutic target.
    Maheaswari R; Sivasankar K; Subbarayan S
    J Indian Soc Periodontol; 2014; 18(6):686-92. PubMed ID: 25624622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of salivary epithelial toll-like receptors 2 and 4 in modulating innate immune responses in chronic periodontitis.
    Swaminathan V; Prakasam S; Puri V; Srinivasan M
    J Periodontal Res; 2013 Dec; 48(6):757-65. PubMed ID: 23679005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of toll-like receptors in gastrointestinal inflammation.
    Ishihara S; Rumi MA; Ortega-Cava CF; Kazumori H; Kadowaki Y; Ishimura N; Kinoshita Y
    Curr Pharm Des; 2006; 12(32):4215-28. PubMed ID: 17100624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
    Hajishengallis G; Sharma A; Russell MW; Genco RJ
    Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Both TLR and NOD Signaling Confers Host Innate Immunity-Mediated Protection Against Microbial Infection.
    Zhou H; Coveney AP; Wu M; Huang J; Blankson S; Zhao H; O'Leary DP; Bai Z; Li Y; Redmond HP; Wang JH; Wang J
    Front Immunol; 2018; 9():3082. PubMed ID: 30692992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.
    Ofodile ON
    J Ind Microbiol Biotechnol; 2007 Dec; 34(12):751-62. PubMed ID: 17876621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors as novel therapeutic targets for herpes simplex virus infection.
    Jahanban-Esfahlan R; Seidi K; Majidinia M; Karimian A; Yousefi B; Nabavi SM; Astani A; Berindan-Neagoe I; Gulei D; Fallarino F; Gargaro M; Manni G; Pirro M; Xu S; Sadeghi M; Nabavi SF; Shirooie S
    Rev Med Virol; 2019 Jul; 29(4):e2048. PubMed ID: 31265195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.
    Ma Z; Cao Q; Xiong Y; Zhang E; Lu M
    Vaccines (Basel); 2018 Jan; 6(1):. PubMed ID: 29337856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
    Ozato K; Tsujimura H; Tamura T
    Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis.
    Beklen A; Hukkanen M; Richardson R; Konttinen YT
    Oral Microbiol Immunol; 2008 Oct; 23(5):425-31. PubMed ID: 18793367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
    Takesue Y; Ohge H; Kohyama M; Imamura Y; Murakami Y; Sueda T
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor-mediated involvement of innate immune cells in asthma disease.
    Zakeri A; Yazdi FG
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3270-3277. PubMed ID: 27543676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate and intrinsic antiviral immunity in skin.
    Kawamura T; Ogawa Y; Aoki R; Shimada S
    J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation].
    Majewska M; Szczepanik M
    Postepy Hig Med Dosw (Online); 2006; 60():52-63. PubMed ID: 16474276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors: the swiss army knife of immunity and vaccine development.
    Dowling JK; Mansell A
    Clin Transl Immunology; 2016 May; 5(5):e85. PubMed ID: 27350884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel drugs targeting Toll-like receptors for antiviral therapy.
    Patel MC; Shirey KA; Pletneva LM; Boukhvalova MS; Garzino-Demo A; Vogel SN; Blanco JC
    Future Virol; 2014 Sep; 9(9):811-829. PubMed ID: 25620999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.